Antitcoagulant and antiplatelet activities of scolymoside

BMB Reports

Volumn 48, Issue 10, 2015, Pages 577-582

  Yoon, Eun Kyung ^a   Ku, Sae Kwang ^b   Lee, Wonhwa ^a,c   Kwak, Soyoung ^a   Kang, Hyejin ^a   Jung, Byeongjin ^a   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Coagulation cascade; Endothelium; Fibrinolysis; Scolymoside

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A; FIBRINOLYTIC AGENT; LUTEOLIN; SCOLYMOSIDE; THROMBIN;

ANIMAL; BLOOD CLOTTING; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; HUMAN; MALE; METABOLISM; MOUSE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CELLS, CULTURED; FACTOR XA; FIBRINOLYTIC AGENTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUTEOLIN; MALE; MICE; MICE, INBRED C57BL; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTHROMBIN TIME; THROMBIN;

EID: 84946207937     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.10.044     Document Type: Article

References (32)

1. Prior RL and Cao G (1999) Antioxidant capacity and polyphenolic components of teas: implications for altering in vivo antioxidant status. Proc Soc Exp Biol Med 220, 255-261
2. Warren CP (1999) Antioxidant effects of herbs. Lancet 353, 676
3. Joubert E, Joubert ME, Bester C, De Beer D and De Lange JH (2011) Honeybush (Cyclopia spp.): From local cottage industry to global markets - The catalytic and supporting role of research. S A J Bot 77, 889-907
4. Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP and Leon-Fernandez OS (2000) Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42, 565-573
5. Leiro JM, Alvarez E, Arranz JA, Siso IG and Orallo F (2003) In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 65, 1361-1371
6. Pardo Andreu GL, Maurmann N, Reolon GK et al (2010) Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats. Eur J Pharmacol 635, 124-128
7. Kazuno S, Yanagida M, Shindo N and Murayama K (2005) Mass spectrometric identification and quantification of glycosyl flavonoids, including dihydrochalcones with neutral loss scan mode. Anal Biochem 347, 182-192
8. Palomo I, Fuentes E, Padro T and Badimon L (2012) Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 3, 577-584
9. Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137, 2493S-2502S
10. Hasler CM, Kundrat S and Wool D (2000) Functional foods and cardiovascular disease. Curr Atheroscler Rep 2, 467-475
11. Philip-Joet F, Alessi MC, Philip-Joet C et al (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 8, 1352-1356
12. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr and Loskutoff DJ (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263, 5797-5803
13. Hamaguchi E, Takamura T, Shimizu A and Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307, 987-994
14. Davie EW (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 74, 1-6
15. Davie EW, Fujikawa K and Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370
16. Quinn C, Hill J and Hassouna H (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin Lab Sci 13, 229-238
17. Lopez S, Peiretti F, Bonardo B, Juhan-Vague I and Nalbone G (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152, 359-366
18. Lee KH (2000) Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 3, 515-522
19. Despotis GJ, Gravlee G, Filos K and Levy J (1999) Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91, 1122-1151
20. Jauch EC, Saver JL, Adams HP Jr et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44, 870-947
21. Wells PS, Forgie MA and Rodger MA (2014) Treatment of venous thromboembolism. JAMA 311, 717-728
22. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D and Poller L (1995) Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108, 258S-275S
23. Pereira MS, Melo FR and Mourao PA (2002) Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans? Glycobiology 12, 573-580
24. Lee W, Yoo H, Ku SK, Kim JA and Bae JS (2013) Anticoagulant activities of piperlonguminine in vitro and in vivo. BMB Rep 46, 484-489
25. Ku SK and Bae JS (2014) Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. BMB Rep 47, 376-381
26. Ku SK and Bae JS (2014) Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa. Arch Pharm Res 37, 1454-1463
27. Kim SY, Kim S, Kim JM et al (2011) PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep 44, 140-145
28. Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J and Wachowicz B (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121, 163-174
29. Bae JS, Lee W, Nam JO, Kim JE, Kim SW and Kim IS (2014) Transforming Growth Factor beta-induced Protein Promotes Severe Vascular Inflammatory Responses. Am J Respir Crit Care Med 189, 779-786
30. Ku SK, Han MS, Lee MY, Lee YM and Bae JS (2014) Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. BMB Rep 47, 336-341
31. Bae JS (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem Toxicol 49, 1572-1577
32. Kim TH, Ku SK and Bae JS (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 113, 2877-2883